Senior insider sale
Chief Financial Officer at BICARA THERAPEUTICS INC. — senior position signals high conviction
$870.8K
44.12K shares
What this filing means
HYEP IVAN plans to sell 44.12K shares of BICARA THERAPEUTICS INC. valued at approximately $870.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/21/2026ACC: 0001969223-26-000585
Officer· Chief Financial Officer
Since Mar 2026
44.12K
Shares to sell
$870.8K
Approx. market value
9.20K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of stock options
Cash
5/21/2026
9.20KTotal acquired9.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/21/2026 | Exercise of stock options Cash | 9.20K | — |
| Total | 9.20K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
9.20K
Market value
$211.6K
4/21/2026
—Completed
Units to sell
9.20K
Market value
$170.3K
3/23/2026
—Completed
Units to sell
2.96K
Market value
$54.1K
3/4/2026
—Completed
Units to sell
13.55K
Market value
$246.9K
3/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.20K
Market value
$187.9K
5/21/2026
Total
Units
44.12K
Value
$870.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/21/2026 | 9.20K | $211.6K | — | Completed |
3/23/2026 | 9.20K | $170.3K | — | Completed |
3/4/2026 | 2.96K | $54.1K | — | Completed |
3/3/2026 | 13.55K | $246.9K | — | Completed |
| Planned — Approximate Date | ||||
5/21/2026 | 9.20K | $187.9K | NASDAQ | Planned |
| Total | 44.12K | $870.8K | ||